Oral Minoxidil 5 mg Versus Minoxidil 5% Topical Solution for the Treatment of Male Androgenetic Alopecia: A Double-Blind Randomized Clinical Trial

    Mariana Alvares [UNESP] Penha
    Studysummary In this study, oral minoxidil at 5 mg/day improved hair density comparably to topical minoxidil 5% in men with androgenetic alopecia over 24 weeks, offering a viable alternative for those intolerant to topical application.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on hdl.handle.net →
    Discuss this study in the Community →